Mary E Keir: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

PD-1 and Its Ligands in Tolerance and Immunity

Freeman, Gordon J., Sharpe, Arlene H., Keir, Mary E., Butte, Manish J.

Journal:

Annual Review of Immunology

Year:

2008

Language:

english

File:

PDF, 461 KB

english, 2008

2

‘Because my brain isn’t as active as it should be, my eyes don’t always see’: a qualitative exploration of the stress process for those living with posterior cortical atrophy

Harding, Emma, Sullivan, Mary Pat, Woodbridge, Rachel, Yong, Keir X X, McIntyre, Anne, Gilhooly, Mary L, Gilhooly, Kenneth J, Crutch, Sebastian J

Journal:

Year:

2018

Language:

english

File:

PDF, 314 KB

english, 2018

3

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies

Dotan, Iris, Allez, Matthieu, Danese, Silvio, Keir, Mary, Tole, Swati, McBride, Jacqueline

Journal:

Medicinal Research Reviews

Year:

2019

Language:

english

File:

PDF, 869 KB

english, 2019

4

PD-1 and its ligands in T-cell immunity

Mary E Keir, Loise M Francisco, Arlene H Sharpe

Journal:

Current Opinion in Immunology

Year:

2007

Language:

english

File:

PDF, 143 KB

english, 2007

5

Synthesis and Structure of a Molecular Barium Aminebis(phenolate) and Its Application as an Initiator for Ring-Opening Polymerization of Cyclic Esters

Davidson, Matthew G., O'Hara, Charles T., Jones, Matthew D., Keir, Callum G., Mahon, Mary F., Kociok-Köhn, Gabriele

Journal:

Inorganic Chemistry

Year:

2007

Language:

english

File:

PDF, 74 KB

english, 2007

6

Zinc(II) Homogeneous and Heterogeneous Species and Their Application for the Ring-Opening Polymerisation of rac-Lactide

Matthew D. Jones, Matthew G. Davidson, Callum G. Keir, Laura M. Hughes, Mary F. Mahon, David C. Apperley

Journal:

European Journal of Inorganic Chemistry

Year:

2009

Language:

english

File:

PDF, 454 KB

english, 2009

7

Spatial trends of polybrominated diphenyl ethers in Canadian fish and implications for long-term monitoring

Sarah B. Gewurtz, Daryl J. McGoldrick, Mandi G. Clark, Michael J. Keir, Mary M. Malecki, Melissa Gledhill, Mark Sekela, Jim Syrgiannis, Marlene S. Evans, Alain Armellin, Joe Pomeroy, Jasmine Waltho, S

Journal:

Environmental Toxicology and Chemistry

Year:

2011

Language:

english

File:

PDF, 400 KB

english, 2011

8

Crystallographic characterisation of novel Zn(II) silsesquioxane complexes and their application as initiators for the production of polylactide

Matthew D. Jones, Callum G. Keir, Andrew L. Johnson, Mary F. Mahon

Journal:

Year:

2010

Language:

english

File:

PDF, 359 KB

english, 2010

9

Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program

Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Lock, Hernan Carol, C. Patrick Reynolds, Nino Keshelava, John M. Maris, Stephen T. Keir, Jianrong Wu, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 321 KB

english, 2008

10

Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program

John M. Maris, Joshua Courtright, Peter J. Houghton, Christopher L. Morton, Richard Gorlick, E. Anders Kolb, Richard Lock, Mayamin Tajbakhsh, C. Patrick Reynolds, Stephen T. Keir, Jianrong Wu, Malcolm

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 336 KB

english, 2008

11

Initial testing of cisplatin by the pediatric preclinical testing program

Mimi Tajbakhsh, Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, John M. Maris, Stephen T. Keir, Jianrong Wu, C. Patrick Reynolds, Malcolm A. Smith, Richard B. Lock

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 514 KB

english, 2008

12

Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program

Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, Richard Lock, Hernan Carol, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Catherine A. Billups, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 410 KB

english, 2008

13

Initial testing of dasatinib by the pediatric preclinical testing program

E. Anders Kolb, Richard Gorlick, Peter J. Houghton, Christopher L. Morton, Richard B. Lock, Mayamin Tajbakhsh, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Catherine A. Billups, Malcolm A. Smi

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 477 KB

english, 2008

14

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

E. Anders Kolb, Richard Gorlick, Peter J. Houghton, Christopher L. Morton, Richard Lock, Hernan Carol, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Catherine A. Billups, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 369 KB

english, 2008

15

Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing program

Richard Lock, Hernan Carol, Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Jianrong Wu, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 451 KB

english, 2008

16

Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program

Malcolm A. Smith, Christopher L. Morton, Doris A. Phelps, E. Anders Kolb, Richard Lock, Hernan Carol, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Jianrong Wu, Peter J. Houghton

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 376 KB

english, 2008

17

Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program

John M. Maris, Joshua Courtright, Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Lock, Mayamin Tajbakhsh, C. Patrick Reynolds, Stephen T. Keir, Jianrong Wu, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2008

Language:

english

File:

PDF, 308 KB

english, 2008

18

Initial testing of aplidin by the pediatric pre-clinical testing program

Christopher L. Morton, Peter J. Houghton, Richard Gorlick, E. Anders Kolb, Richard Lock, Hernan Carol, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, John M. Maris, Catherine Billups, Malcolm A. S

Journal:

Pediatric Blood & Cancer

Year:

2009

Language:

english

File:

PDF, 64 KB

english, 2009

19

Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program

Nino Keshelava, Peter J. Houghton, Christopher L. Morton, Richard B. Lock, Hernan Carol, Stephen T. Keir, John M. Maris, C. Patrick Reynolds, Richard Gorlick, E. Anders Kolb, Jianrong Wu, Malcolm A. S

Journal:

Pediatric Blood & Cancer

Year:

2009

Language:

english

File:

PDF, 65 KB

english, 2009

20

Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program

Hernan Carol, Richard Lock, Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Catherine A. Billups, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2009

Language:

english

File:

PDF, 612 KB

english, 2009

21

Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing program

Malcolm A. Smith, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, Stephen T. Keir, Hernan Carol, Richard Lock, Min H. Kang, C. Patrick Reynolds, John M. Maris, Amy E. Watkins, Peter J. Houghto

Journal:

Pediatric Blood & Cancer

Year:

2010

Language:

english

File:

PDF, 111 KB

english, 2010

22

Initial testing of topotecan by the pediatric preclinical testing program

Hernan Carol, Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, C. Patrick Reynolds, Min H. Kang, John M. Maris, Stephen T. Keir, Amy Watkins, Malcolm A. Smith, Richard B. Loc

Journal:

Pediatric Blood & Cancer

Year:

2010

Language:

english

File:

PDF, 547 KB

english, 2010

23

Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the pediatric preclinical testing program

Peter J. Houghton, Christopher L. Morton, Richard Gorlick, E. Anders Kolb, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, John M. Maris, Jianrong Wu, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2010

Language:

english

File:

PDF, 280 KB

english, 2010

24

Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)

John M. Maris, Christopher L. Morton, Richard Gorlick, E. Anders Kolb, Richard Lock, Hernan Carol, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, Jianrong Wu, Malcolm A. Smith, Peter J. Houghton

Journal:

Pediatric Blood & Cancer

Year:

2010

Language:

english

File:

PDF, 413 KB

english, 2010

25

Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program

Christopher L. Morton, Peter J. Houghton, E. Anders Kolb, Richard Gorlick, C. Patrick Reynolds, Min H. Kang, John M. Maris, Stephen T. Keir, Jianrong Wu, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2010

Language:

english

File:

PDF, 446 KB

english, 2010

26

Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program

E. Anders Kolb, Richard Gorlick, Peter J. Houghton, Christopher L. Morton, Geoffrey Neale, Stephen T. Keir, Hernan Carol, Richard Lock, Doris Phelps, Min H. Kang, C. Patrick Reynolds, John M. Maris, C

Journal:

Pediatric Blood & Cancer

Year:

2010

Language:

english

File:

PDF, 622 KB

english, 2010

27

Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing program

Stephen T. Keir, John M. Maris, Richard Lock, E. Anders Kolb, Richard Gorlick, Hernan Carol, Christopher L. Morton, C. Patrick Reynolds, Min H. Kang, Amy Watkins, Peter J. Houghton, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2010

Language:

english

File:

PDF, 356 KB

english, 2010

28

Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program

E. Anders Kolb, Richard Gorlick, Richard Lock, Hernan Carol, Christopher L. Morton, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, John M. Maris, Catherine Billups, Malcolm A. Smith, Peter J. Houg

Journal:

Pediatric Blood & Cancer

Year:

2011

Language:

english

File:

PDF, 1.41 MB

english, 2011

29

Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program

Hernan Carol, Christopher L. Morton, Richard Gorlick, E. Anders Kolb, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, John M. Maris, Catherine Billups, Malcolm A. Smith, Peter J. Houghton, Richard

Journal:

Pediatric Blood & Cancer

Year:

2010

Language:

english

File:

PDF, 440 KB

english, 2010

30

Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program

Malcolm A. Smith, John M. Maris, Richard Lock, E. Anders Kolb, Richard Gorlick, Stephen T. Keir, Hernan Carol, Christopher L. Morton, C. Patrick Reynolds, Min H. Kang, Peter J. Houghton

Journal:

Pediatric Blood & Cancer

Year:

2011

Language:

english

File:

PDF, 1.32 MB

english, 2011

31

Initial testing of lenalidomide by the pediatric preclinical testing program

C. Patrick Reynolds, Min H. Kang, Stephen T. Keir, Richard Gorlick, E. Anders Kolb, Richard Lock, John M. Maris, Hernan Carol, Christopher L. Morton, Catherine A. Billups, Malcolm A. Smith, Peter J. H

Journal:

Pediatric Blood & Cancer

Year:

2011

Language:

english

File:

PDF, 102 KB

english, 2011

32

Initial testing of the hypoxia-activated prodrug PR-104 by the pediatric preclinical testing program

Peter J. Houghton, Richard Lock, Hernan Carol, Christopher L. Morton, Doris Phelps, Richard Gorlick, E. Anders Kolb, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, John M. Maris, Amy W. Wozniak, Y

Journal:

Pediatric Blood & Cancer

Year:

2011

Language:

english

File:

PDF, 1.73 MB

english, 2011

33

Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing program

Peter J. Houghton, Richard Gorlick, E. Anders Kolb, Richard Lock, Hernan Carol, Christopher L. Morton, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, Doris Phelps, John M. Maris, Catherine Billups

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 816 KB

english, 2012

34

Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing program

Peter J. Houghton, Richard Lock, Hernan Carol, Christopher L. Morton, Richard Gorlick, E. Anders Kolb, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, John M. Maris, Catherine A. Billups, Mindy X.

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 490 KB

english, 2012

35

Diagnosis of congenital disorders of glycosylation type-I using protein chip technology

Kevin Mills, Philippa Mills, Marie Jackson, Viki Worthington, Clare Beesley, Anúska Mann, Peter Clayton, Stephanie Grunewald, Geoffrey Keir, Liz Young, James Langridge, Nasi Mian, Bryan Winchester

Journal:

Year:

2006

Language:

english

File:

PDF, 553 KB

english, 2006

36

Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer

Hernan Carol, Ingrid Boehm, C. Patrick Reynolds, Min H. Kang, John M. Maris, Christopher L. Morton, Richard Gorlick, E. Anders Kolb, Stephen T. Keir, Jianrong Wu, Amy E. Wozniak, Yu Yang, Mark Manfred

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 2.03 MB

english, 2011

37

The B7/CD28 costimulatory family in autoimmunity

Mary E. Keir, Arlene H. Sharpe

Journal:

Immunological Reviews

Year:

2005

Language:

english

File:

PDF, 993 KB

english, 2005

38

Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing program

Min H. Kang, C. Patrick Reynolds, Peter J. Houghton, Denise Alexander, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, Stephen T. Keir, Hernan Carol, Richard Lock, John M. Maris, Amy Wozniak,

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 78 KB

english, 2012

39

Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program

Christopher L. Morton, John M. Maris, Stephen T. Keir, Richard Gorlick, E. Anders Kolb, Catherine A. Billups, Jianrong Wu, Malcolm A. Smith, Peter J. Houghton

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 336 KB

english, 2012

40

Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing program

E. Anders Kolb, Richard Gorlick, John M. Maris, Stephen T. Keir, Christopher L. Morton, Jianrong Wu, Amy W. Wozniak, Malcolm A. Smith, Peter J. Houghton

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 668 KB

english, 2012

41

Initial testing (stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing program

Peter J. Houghton, Min H. Kang, C. Patrick Reynolds, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, Stephen T. Keir, Hernan Carol, Richard Lock, John M. Maris, Catherine A. Billups, Malcolm A

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 76 KB

english, 2012

42

Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program

Richard B. Lock, Hernan Carol, Christopher L. Morton, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, John M. Maris, Amy W. Wozniak, Richard Gorlick, E. Anders Kolb, Peter J. Houghton, Malcolm A. S

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 522 KB

english, 2012

43

Initial testing of JNJ-26854165 (Serdemetan) by the pediatric preclinical testing program

Malcolm A. Smith, Richard Gorlick, E. Anders Kolb, Richard Lock, Hernan Carol, John M. Maris, Stephen T. Keir, Christopher L. Morton, C. Patrick Reynolds, Min H. Kang, Janine Arts, Tarig Bashir, Miche

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 78 KB

english, 2012

44

Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling

E. Anders Kolb, Richard Gorlick, Stephen T. Keir, John M. Maris, Richard Lock, Hernan Carol, Raushan T. Kurmasheva, C. Patrick Reynolds, Min H. Kang, Jianrong Wu, Peter J. Houghton, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 376 KB

english, 2012

45

Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program

Malcolm A. Smith, John M. Maris, Richard Gorlick, E. Anders Kolb, Richard Lock, Hernan Carol, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, Christopher L. Morton, Jianrong Wu, Peter G. Smith, Jie

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 496 KB

english, 2012

46

Testing of the Akt/PKB inhibitor MK-2206 by the pediatric preclinical testing program

Richard Gorlick, John M. Maris, Peter J. Houghton, Richard Lock, Hernan Carol, Raushan T. Kurmasheva, E. Anders Kolb, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, Catherine A. Billups, Malcolm A

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 426 KB

english, 2012

47

Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing program

Vandana Batra, John M. Maris, Min H. Kang, C. Patrick Reynolds, Peter J. Houghton, Denise Alexander, E. Anders Kolb, Richard Gorlick, Stephen T. Keir, Hernan Carol, Richard Lock, Catherine A. Billups,

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 71 KB

english, 2012

48

Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing program

Richard Gorlick, E. Anders Kolb, Peter J. Houghton, Christopher L. Morton, Geoffrey Neale, Stephen T. Keir, Hernan Carol, Richard Lock, Doris Phelps, Min H. Kang, C. Patrick Reynolds, John M. Maris, C

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 665 KB

english, 2012

49

Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program

Christopher L. Morton, Peter J. Houghton, E. Anders Kolb, Richard Gorlick, C. Patrick Reynolds, Min H. Kang, John M. Maris, Stephen T. Keir, Jianrong Wu, Malcolm A. Smith

Journal:

Pediatric Blood & Cancer

Year:

2012

File:

PDF, 90 KB

2012

50

Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program

Hernan Carol, C. Patrick Reynolds, Min H. Kang, Stephen T. Keir, John M. Maris, Richard Gorlick, E. Anders Kolb, Catherine A. Billups, Brian Geier, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A.

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 753 KB

english, 2012